CEBPA and acute myeloid leukemia: In our hands, we were also unable to generate iPSC from the patient after disease progression harbouring a mutation disrupting the CEBPA bZIP domain (Gly257fs), highlighting that the complex genetic background of high-risk MDS and AML patients dictates the ability of generating iPSC.